Finnegan, Henderson, Farabow, Garrett & Dunner, LLP With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in the United States, Europe, and Asia, we work with leading innovators to protect, advocate, and leverage their most important IP assets. We handle all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation, with particular experience in Abbreviated New Drug Application (ANDA) and biotechnology cases. Our Biotechnology/Pharmaceutical Practice Group includes 86 professionals, many of whom hold advanced degrees and have substantial research experience. In addition, 63 members of the group are registered to practice before the U.S. Patent and Trademark Office, and five are former patent examiners. We represent branded clients of every size and in a wide range of biotechnology and pharmaceutical specialty areas—from new ventures safeguarding their first revolutionary idea to global corporations owning some of the largest and most valuable IP portfolios. Through our work, we have first-hand experience in cutting-edge advances such as genomics, immunology, nanotechnology, proteomics, transgenics, virology, sustained-released drug formulations, and new chemical entities (NCEs). For more information, please visit www.finnegan.com